Exchange: NASDAQ·Updated 07:30 PM EDT
QNCX logo

QNCX Quince Therapeutics Inc

$28.96
$1.36
(4.47%)
Today
Closed $28.96
$0.00
(0.00%)
After Hours
Reported EarningsAug 14
Mkt Cap$30.83M
Vol3,635.00

About QNCX

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
33

Bearish Sentiment

How do you feel about QNCX?

Advertisement|Remove ads.